Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Targeting CGRP in migraine: a matter of choice and dose.

< BACK TO ARCHIVE


Papers: 22 Aug 2020 - 28 Aug 2020


Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2020 Sep


Lancet Neurol


http://www.ncbi.nlm.nih.gov/pubmed/32822621?dopt=Abstract


19


9

Targeting CGRP in migraine: a matter of choice and dose.

Authors

Targeting CGRP in migraine: a matter of choice and dose.
Al-Hassany L, Maassen Van Den Brink A
Lancet Neurol. 2020 Sep; 19(9):712-713.
PMID: 32822621.
Read This Paper